Revelation Biosciences Inc's Customers Performance

Name: Revelation Biosciences Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

REVB

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


REVB's Source of Revenues		• List of REVB Customers

for the same period Revelation Biosciences Inc

• List of REVB Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Revelation Biosciences Inc's Comment on Sales, Marketing and Customers

News about Revelation Biosciences Inc Contracts

Strategic Maneuver Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split to Optimize Market Position

: Revelation Biosciences Inc. a player in the biopharmaceutical sector, has announced a significant corporate decision to implement a 1-for-16 reverse stock split, effective January 28, 2025. This strategic move comes after approval from the company s Special Meeting of Stockholders on January 17, 2025. The necessity for this action arises within the context of the company’s year-to-date performance in the market, suggesting a need for recalibrating its stock structure to foster enhanced market conditions and shareholder value.: In the intricate landscape of pharmaceutical investments, corporate strategies such as reverse stock splits are often indicative of a company’s efforts to realign its equity str...

Strategic Financial Restructuring Revelation Biosciences Implements a 1-for-16 Reverse Stock Split

In a significant development illustrating the company s commitment to enhancing shareholder value and financial positioning, Revelation Biosciences Inc. (NASDAQ: REVB) has announced a 1-for-16 reverse stock split effective January 28, 2025. This decision follows the approval granted during the Special Meeting of Stockholders held on January 17, 2025, signaling a transformative step for the organization.Reverse stock splits are strategic maneuvers employed by corporations to consolidate shares, thereby potentially increasing the market price of each share by reducing the total number of outstanding shares. For Revelation Biosciences, this move is anticipated to enhance the perception of the company s stock by...

Revelation Biosciences Inc. to Present Groundbreaking Preclinical Data on Gemini for Acute Kidney Injury Prevention at Prestigious International Conference

Revelation Biosciences Inc. (NASDAQ: REVB), a leading biotech company focused on innovative treatments for critical conditions, has received a prestigious invitation to deliver an oral presentation at The 29th International Conference on Advances in Critical Care Nephrology. The conference, commonly known as AKI and CRRT 2024, will be held in San Diego from March 12-15, 2024. Revelation Biosciences was selected as one of a limited number of accepted abstract authors, providing them with a unique opportunity to share their groundbreaking preclinical data on the potential therapeutic benefit of Gemini for the prevention of acute kidney injury (AKI).Acute kidney injury is a severe condition with high mortality ...

REVB's Stock Performance relative to it's Customers

REVB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Revelation Biosciences Inc	3.82	0.00	-21.50	9
SUBTOTAL	0.00	0.00	0.00	-

Sources: Revelation Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Revelation Biosciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Revelation Biosciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.